Company
Beam Therapeutics Inc BEAM
Tracked across 1 disclosed holder on Protégé.
Held by these investors
| Investor | % of portfolio | Value |
|---|---|---|
| Farallon Capital Management | 2.1% | $351.3M |
Company
Tracked across 1 disclosed holder on Protégé.
| Investor | % of portfolio | Value |
|---|---|---|
| Farallon Capital Management | 2.1% | $351.3M |